Viswanathan, Lakshmi
Bachman, Eric
Tian, Simon
Ahluwalia, Neil
Zhang, Yaohua
Bernstein, Harold S.
Panorchan, Paul
Funding for this research was provided by:
Vertex Pharmaceuticals
Article History
Accepted: 31 July 2022
First Online: 29 August 2022
Declaration
:
: All authors received nonfinancial assistance (assistance with manuscript preparation) from ArticulateScience LLC, which received funding from Vertex Pharmaceuticals Incorporated. All authors are current or former employees of Vertex Pharmaceuticals and may own stock or stock options in the company.
: This study was funded by Vertex Pharmaceuticals Incorporated.
: Vertex is committed to advancing medical science and improving patient health. This includes the responsible sharing of clinical trial data with qualified researchers. Proposals for the use of these data will be reviewed by a scientific board. Approvals are at the discretion of Vertex and will be dependent on the nature of the request, the merit of the research proposed, and the intended use of the data. Please contact CTDS@vrtx.com if you would like to submit a proposal or need more information.
: Not applicable.
: This study was conducted in accordance with the current Good Clinical Practice Guidelines as described by the International Council for Harmonization, the Declaration of Helsinki, and local applicable laws and regulations. The study protocol and informed consent forms were reviewed and approved by an independent ethics committee or internal review board for each study site.
: Each enrolled subject provided informed consent.
: Not applicable.
: The study was designed by Vertex Pharmaceuticals Incorporated. Data gathering and analysis were performed by Vertex Pharmaceuticals Incorporated. All authors contributed to the study concept or design. LV and EB were responsible for the acquisition of data. All authors participated in the analysis and interpretation of study data, drafted and critically revised the manuscript, and gave final approval of the manuscript for publication.